FDA.reportPublic FDA data

Tirosint 13 MCG Oral Capsule

RxCUI
966434
RxNorm name
Tirosint 13 MCG Oral Capsule
Display name
Tirosint 13 MCG Oral Capsule
Full name
Tirosint 13 MCG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TirosintLEVOTHYROXINE SODIUMIBSA Pharma Inc.7a7ade79-0165-4e31-b84e-667416c00c7e2026-03-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966434

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7a7ade79-0165-4e31-b84e-667416c00c7eTirosint 13 MCG Oral Capsule [PSN] · levothyroxine sodium 0.013 MG Oral Capsule [Tirosint] [SBD] · Tirosint 0.013 MG Oral Capsule [SY] · Tirosint 13 MCG Oral Capsule [SY]413These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 200020260325